Page last updated: 2024-10-30

meclofenamic acid and Autosomal Recessive Chronic Granulomatous Disease

meclofenamic acid has been researched along with Autosomal Recessive Chronic Granulomatous Disease in 1 studies

Meclofenamic Acid: A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
meclofenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Archer, SL1
Reeve, HL1
Michelakis, E1
Puttagunta, L1
Waite, R1
Nelson, DP1
Dinauer, MC1
Weir, EK1

Other Studies

1 other study available for meclofenamic acid and Autosomal Recessive Chronic Granulomatous Disease

ArticleYear
O2 sensing is preserved in mice lacking the gp91 phox subunit of NADPH oxidase.
    Proceedings of the National Academy of Sciences of the United States of America, 1999, Jul-06, Volume: 96, Issue:14

    Topics: Animals; Blood Pressure; Granulomatous Disease, Chronic; Hemodynamics; Hypoxia; In Vitro Techniques;

1999